Women Under Study LLC

1. SCYNEXIS, Inc. $251,320 8 payments
2. BioNTech SE $182,692 82 payments
3. Pfizer Inc. $157,685 26 payments
4. AbbVie, Inc. $38,944 27 payments

1. SCY-078-307b $233,575 3 payments
2. Bnt331-01 $182,692 82 payments
3. A Phase 3 Randomized Doubleblinded Placebocontrolled Trial to Evaluate the Efficacy and Safety of A Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy $132,685 24 payments
4. A Phase 2 Placebocontrolled Randomized Proof of Concept Study of A Respiratory Syncytial Virus RSV Vaccine in Pregnant Women $25,000 2 payments
5. Scy-078-304_086551 $17,745 5 payments
6. Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women $13,672 8 payments
7. A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain $13,349 7 payments
8. Long-Term Safety Study of Elagolix in Combination With Estradiol;Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women $5,374 7 payments
9. Long-Term Safety Study of Elagolix in Combination With Estradiol Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women $3,650 1 payment
10. A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain $1,829 1 payment

1. Patient care $247,420 6 payments
2. Overhead $3,900 2 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.